Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.

He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot.